Achema middle east

News

400 Global Regulatory Manufacturing Approvals for Samsung Biologics

Samsung Biologics announced on November 26, 2025, that it has gone on to achieve a whopping 400 regulatory manufacturing approvals all over the world due to its...

Clinical Trial Services and the Role of a European CRO

Conducting a clinical trial today requires coordinated procedures, standardized documentation, and a clear understanding of the regulatory systems that govern research. As more studies extend...

AstraZeneca, Biopharma Giant, Announces $2bn Investment in Maryland

It should not be termed as an overstatement when we say that Maryland is fast becoming the home away from home when it comes to...

FDA Looks to Accelerate Biosimilar Drug Development

The FDA has gone on to propose certain new policies in order to accelerate biosimilar drug development and at the same time also lower the...

Onshoring of Drug Product Manufacturing to Massachusetts

Moderna is set to expand its US manufacturing capabilities through the onshoring of drug product manufacturing to its present Moderna Technology Center - MTC located Norwood,...

Australian Biopharma to Expand US Plasma-Derived Therapies

The Australian-based biopharma company, CSL, plans to invest almost $1.5 billion in the next five years so as to expand its presence in the U.S....

Pfizer to Acquire Metsera in a $10bn Deal as Board Backs

The news of Pfizer to acquire Metsera in a $10bn deal has indeed caught the eye of many. Metsera happens to be a US-based biotechnology...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »